Psychiatry and Neurology, Neurology · Saint Louis, MO
NPI
1497783997
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3009 N Ballas Rd Ste 105b
Saint Louis, MO, 63131
Phone (314) 996-7960
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
457 services
Medicare patients, 2024
180
Average age 66
Drug cost, 2024
$3.0M
4,061 prescriptions
Company payments, 2025
$8,185
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barbara J Green was code 99215 (office e&m - established), 211 times for 149 patients. In total Barbara J Green billed 457 services in 7 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 211 | 149 | $120.69 | $25K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 165 | 136 | $12.60 | $2,079 |
| 99214 Office E&M - Established | Office | 73 | 65 | $85.41 | $6,235 |
By year: 2022 $33K for 294 services; 2023 $34K for 300 services; 2024 $35K for 457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barbara J Green prescribed most often to Medicare patients was Gabapentin, with 388 prescriptions and refills. In total Barbara J Green wrote 4,061 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 388 | 667 | 80 | $9,517 |
| Baclofen Generic | 294 | 545 | 65 | $5,817 |
| Dalfampridine Er Dalfampridine | 228 | 309 | 34 | $66K |
| Teriflunomide Generic | 196 | 206 | 27 | $95K |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 121 | 121 | 25 | $3,106 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 121 | 121 | 19 | $2,275 |
| Duloxetine Hcl Generic | 115 | 219 | 19 | $2,533 |
| Carbamazepine Er Carbamazepine | 114 | 190 | 19 | $9,632 |
| Modafinil Generic | 107 | 151 | 24 | $8,077 |
| Tizanidine Hcl Generic | 105 | 202 | 22 | $2,026 |
| Clonazepam Generic | 101 | 109 | 12 | $692 |
| Alprazolam Generic | 99 | 105 | 22 | $217 |
| Tramadol Hcl Generic | 95 | 95 | 12 | $784 |
| Diazepam Generic | 94 | 105 | 23 | $881 |
| Lorazepam Generic | 82 | 90 | 14 | $777 |
Brand drugs: 342 claims; generic drugs: 3,719 claims; opioid claims: 289.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barbara J Green $8,185 ($8,185 in general payments such as food, travel and fees) from 8 companies. The largest payer was Vanda Pharmaceuticals Inc. with $7,638.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.